As the prevalence of cardiovascular disease (CVD) continues to grow, Rhys Tassell, Point of Care Testing Team Lead at Cambridge University Hospitals NHS Foundation Trust, …

Getting the right medicine into the hands of a patient in a timely manner has always been the ultimate goal in the clinical supply chain, …

In this article, Sarah Ray, Senior Research Analyst, explores the following issue: amidst a regulatory environment which increasingly focuses on evidence-based research, many life science …

A Two-step Pre-screening Process Before Site Referral Improves Efficiency and Reduces Costs  Clinical trial recruitment involves three distinct phases: (1) Connecting with patients through advertising …

According to this article from Charlotte Housden, Head of the Biotechnology and Research Business Unit at Cambridge Cognition, there is increasing pressure on pharmaceutical companies …

Riin Ehin, Chairwoman of the Board and CEO of Competence Centre for Cancer Research, partner and CEO of Bravo Healthcare Ltd., submits a paper on …

As Markku Toivonen, MD, PhD, chairman of CHMP Scientific Advice Working Party, explains in this piece, according to current evidence, Alzheimer’s disease (AD) is a …

Mona Dawood, Head of the Pharmaceutical Operations & Regulatory Affairs for CIDP Group, provides an insightful report on Singapore, a fascinating country full of lively …

With the growth of comparative effectiveness research (CER) and the need for large volumes of active comparator medicines comes an increased demand for effective sourcing …

Each year, Veeva surveys the pharmaceutical industry on its use of trial master file (TMF) processes. Within this article, Rik van Mol, Vice President of …